Exodus Point Capital Management, LP Accelerate Diagnostics, Inc Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.31 - $8.25 $174,040 - $270,402	-32,776 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $149,670 - $202,856	21,978 Added 203.54%	32,776 $264,000
Q1 2021 May 17, 2021	BUY	$7.99 - $15.0 $86,276 - $161,970	10,798 New	10,798 $90,000
Q4 2020 Feb 16, 2021	SELL	$7.04 - $11.7 $123,080 - $204,551	-17,483 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $174,480 - $315,393	17,483 New	17,483 $186,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $114M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.